NO. 07-10-0507-CV
IN THE COURT OF APPEALS
FOR THE SEVENTH DISTRICT OF TEXAS
AT AMARILLO
PANEL C
AUGUST 16, 2011
______________________________
MICHELLE MOORE, APPELLANT
V.
THE STATE OF TEXAS, APPELLEE
_________________________________
FROM COUNTY COURT AT LAW NO. 1 OF LUBBOCK COUNTY;
NO. 2009-458,735; HONORABLE DRUE FARMER, JUDGE
_______________________________
Before QUINN, C.J., and HANCOCK and PIRTLE, JJ.
MEMORANDUM OPINION
By this
accelerated appeal, Appellant, Michelle Moore appeals the trial court's Order Authorizing Psychoactive Medications issued
following a Judgment of Commitment
Following Competency Exam Incompetent But Likely to
Regain Competency. By two issues, Appellant contests the legal
and factual sufficiency of the evidence to support that order. We modify the trial court's order and, as
modified, affirm.
I. Background Facts
Appellant
is a female in her mid-forties who has been diagnosed with schizoaffective
disorder with a bipolar component. She
also experiences grandiose delusions. After her house was repossessed, in 2003, she
moved into a small trailer in her parents' backyard. According to her mother, she has credit card
debt and no financial resources. Her mother
testified that Appellant talks to herself and leaves town for brief periods
only to be brought back by police. In
2005, she was temporarily committed for treatment after a former boss
threatened to take action if something was not done about her behavior. At that time she was diagnosed with paranoid
schizophrenia but did not present with an affective mood component. She was treated with Risperdal,
a psychoactive medication. However, she
stopped taking her medication because she felt "normal."
On November 25, 2009, she was
arrested for a nonviolent criminal trespass. On August 4, 2010, a competency evaluation
was conducted by Dr. Robert D. Morgan to determine whether Appellant was
competent to stand trial on the criminal trespass charge. Dr. Morgan concluded that with psychotropic
medications and treatment, Appellant could be restored to competency. He recommended that Appellant participate in treatment
on an outpatient basis but cautioned that if she was not compliant with the
medication it would be necessary to transfer her to inpatient treatment.
On
September 13, 2010, Appellant was ordered to participate in an outpatient
program at Sunrise Canyon Hospital. Dr.
Dianna Kucera, a psychologist, had an initial consultation
with Appellant on October 10, 2010, to explain the competency restoration
process. Appellant made it clear to Dr. Kucera that she had no interest in taking antipsychotic
medications as part of her treatment.
For
undetermined reasons, Appellant did not show for her next scheduled appointment
and on November 1, 2010, the trial court signed an order committing her to
Sunrise Canyon Hospital to undergo treatment on an inpatient basis. According to the judgment of commitment,
Appellant was ordered to be held for a period not to exceed 120 days.
On
December 8, 2010, pursuant to the Texas Health and Safety Code, Dr. Marsha
Spalding, Medical Director for the Lubbock Regional Mental Health and Mental
Retardation Center, filed an Application for
Order to Administer Psychoactive Medication to Appellant. In her application she provided, "[p]atient
will continue to be unable to meet her basic needs and will continue to
deteriorate mentally, placing herself at ongoing risk." Following
a hearing on the application, the trial court signed the order authorizing
Appellant to be treated with psychoactive medication during her inpatient
commitment. That order is the subject of
this appeal.
II. Burden of Proof and
Standards of Review
In the case
at hand, the State sought to obtain an order authorizing the involuntary
administration of psychoactive medications to Appellant pursuant to the
provisions of section 574.104 of the Texas Health & Safety Code. See Tex.
Health & Safety Code Ann. § 574.104 (West 2010). Pursuant to that section, following a hearing
held pursuant to the provisions of section 574.106, a trial court may issue an
order authorizing the administration of one or more classes of psychoactive
medications to a patient who:
(1) is
under a court order to receive inpatient mental health services; or
(2) is
in custody awaiting trial in a criminal proceeding and was ordered to receive
inpatient mental health services in the six months preceding a hearing under
this section.
See §
574.106(a).
A. Legal Sufficiency
In evaluating evidence for legal
sufficiency, we review all the evidence in the light most favorable to the
finding to determine whether a reasonable factfinder could have formed a firm
belief or conviction that the finding was true.
In re J.F.C.,
96 S.W.3d at 266. We resolve
disputed fact questions in favor of the finding if a reasonable factfinder
could have done so. City of Keller v. Wilson, 168 S.W.3d
802, 817 (Tex. 2005); In re J.F.C.,
96 S.W.3d at 266.
B. Factual Sufficiency
In
reviewing the factual sufficiency to support the finding, we ask whether the
evidence is such that a factfinder could reasonably form a firm belief or
conviction about the truth of the State's allegations. In re J.F.C., 96 S.W.3d at 266. If, in light of the entire record, the
disputed evidence that a reasonable factfinder could not have credited in favor
of the finding is so significant that a factfinder could not reasonably have
formed a firm belief or conviction, then the evidence is factually
insufficient. Id. An appellate court
should detail in its opinion why it has concluded that a reasonable factfinder
could not have credited disputed evidence in favor of the finding. Id. at 266-67.
III. Applicable Law
Appellant
does not challenge the trial court's November 1, 2010 Judgment of Commitment, committing her to the Sunrise Canyon
Hospital for inpatient mental health services.
Therefore, we will only review Appellant's legal and factual sufficiency
challenges to the trial court's order authorizing the involuntary
administration of psychoactive medications.
Pursuant
to the provisions of section 574.106(a-1), a trial court may issue an order authorizing
psychoactive medication only if it finds by clear and convincing evidence after
the hearing:
(1) that
the patient lacks the capacity to make a decision regarding the administration
of the proposed medication and treatment with the proposed medication is in the
best interest of the patient; or
(2) if
the patient was ordered to receive inpatient mental health services by a
criminal court with jurisdiction over the patient, that treatment with the
proposed medication is in the best interest of the patient and either:
(A) the patient presents a
danger to the patient or others in the inpatient mental health facility in
which the patient is being treated as a result of a mental disorder or mental
defect as determined under Section 574.1065; or
(B) the
patient:
(i)
has remained confined in a correctional facility . . . for a period exceeding
72 hours while awaiting transfer for competency restoration treatment; and
(ii) presents
a danger to the patient or others in the correctional facility as a result of a
mental disorder or mental defect as determined under Section 574.1065.
See §
574.106(a-1). (Emphasis added).
In
making a best interest finding, the trial court shall consider:
(1) the
patient's expressed preferences regarding treatment with psychoactive
medication;
(2) the
patient's religious beliefs;
(3) the
risks and benefits, from the perspective of the patient, of taking psychoactive
medication;
(4) the
consequences to the patient if the psychoactive medication is not administered;
(5) the
prognosis for the patient if the patient is treated with psychoactive
medication;
(6) alternative,
less intrusive treatments that are likely to produce the same results as
treatment with psychoactive medication; and
(7) less
intrusive treatments likely to secure the patient's agreement to take the
psychoactive medication.
See § 574.106(b).
IV. Analysis
As used in section 547.106(a-1)(1),
capacity means a patient's ability to (1) understand the nature and
consequences of a proposed treatment, including the benefits, risks, and
alternatives to the proposed treatment, and (2) make a decision whether to
undergo the proposed treatment. §
574.101(1).
Dr. Spalding testified
unequivocally that Appellant lacks the capacity to determine whether to take
medication because she does not believe she has a mental illness. According to
her outpatient clinic chart, Appellant has been noncompliant with her
medication since 1997. Regarding Dr. Vahora's testimony on lack of capacity, we agree with
Appellant that he began with a conclusory statement, i.e., "I understand
she is mentally ill and, therefore, requires medication." However, he then explained that she suffers
from persecutory delusions and has no judgment or insight. He also echoed Dr. Spalding's testimony that
Appellant does not believe she has a mental illness.
During the hearing on the application
to administer psychoactive medication, Dr. Spalding testified she wanted to
treat Appellant with the injectable form of Risperdal, a psychoactive medication, and Ativan, an anti-anxiety medication. She explained that Ativan
is administered to help relieve anxiety because Risperdal
takes two weeks to become effective. She
explained her preference for the injectable form over
the oral form because there would be no need to remember a daily pill and staff
does not "shove medicine down patients' throats . . . ." Dr. Spalding's treatment would include
beginning with a low dosage and careful monitoring for side effects. The most common side effects are sedation and
symptoms resembling those of Parkinson's disease. Dr. Spalding also testified that first
generation anti-psychotics could produce tardive dyskinesia (TD), a neurological condition with unpleasant
side effects. However, according to Dr.
Spalding, she has never seen extreme side effects of TD with Risperdal, which is a second-generation medication. Dr. Spalding was confident that if a patient
remains on Risperdal, TD would not present itself.
Dr. Vahora
testified that Appellant had been treated with Risperdal
when previously committed in 2005, but ceased taking the drug because she felt
"normal." Dr. Spalding testified
that Appellant denied having taken Risperdal in the
past. The expert testimony and
Appellant's resistance to medication demonstrates Appellant's lack of capacity
to understand that nature and consequences of a proposed treatment and her
inability to make a decision to undergo treatment. The trial court's finding on lack of capacity
is supported by clear and convincing evidence.
Conclusion
Having concluded there was no
evidence to support the trial court's finding that
"[Appellant] presents a danger to herself or others in Sunrise Canyon
Hospital as a result of mental illness as determined under Section 574.106 of
the Texas Health and Safety Code," we delete that finding from the trial
court's order. As modified, we affirm
the trial court's Order Authorizing
Psychoactive Medications.
Patrick A. Pirtle
Justice